25 results
8-K
EX-99.1
HUMA
Humacyte Inc
29 Feb 24
Other Events
4:02pm
Bioengineering Platform Platform targets extensive markets across multiple indications Extensive Markets Existing facilities expected to support anticipated
424B7
HUMA
Humacyte Inc
27 Oct 21
Prospectus with selling stockholder info
2:42pm
from these grants upon the achievement of performance milestones related to patient enrollment targets before this program ended in 2020. The Company
8-K
EX-99.1
01wh28c548yjh
27 Aug 21
Report of Independent Registered Public Accounting Firm
9:01pm
S-4/A
jxg oq1s2c5foy
14 Jun 21
Registration of securities issued in business combination transactions (amended)
12:00am
CORRESP
msldkyq go
11 Jun 21
Correspondence with SEC
12:00am
10-K/A
4xxypg k0o7s
14 May 21
Annual report (amended)
4:04pm
UPLOAD
mdvzkvkykp
22 Apr 21
Letter from SEC
12:00am
S-4
EX-10.3
1gzf2q9 1jcuwwah21
23 Mar 21
Registration of securities issued in business combination transactions
12:00am
S-4
mveid5x1
23 Mar 21
Registration of securities issued in business combination transactions
12:00am
8-K
EX-10.1
bj1jvlewf yo
17 Feb 21
Entry into a Material Definitive Agreement
8:45am
8-K
EX-2.1
agrvmqu
17 Feb 21
Entry into a Material Definitive Agreement
8:45am
425
EX-10.1
25un102iyv3kgw707mb
17 Feb 21
Business combination disclosure
8:43am
425
EX-2.1
jhazf1c7bvg56v
17 Feb 21
Business combination disclosure
8:43am
10-K
15z5vo z0nsd1vl0a
16 Feb 21
Annual report
4:02pm